ClearPoint Neuro WKN: A2PZ3E ISIN: US18507C1036 Kürzel: CLPT Forum: Aktien Thema: Hauptdiskussion

Die Zulassung bei Boston Scientific hat hier heute einen schönen Schub verliehen: https://stocktwits.com/jlivermore1929/message/276204186

.

Sind hier Kurse von über 100$ denkbarß die Pipeline ist ja riesig...

🍀

ClearPoint Neuro, Inc. Announces First Procedure Utilizing ClearPoint 2.0 Software in Europe https://www.globenewswire.com/news-release/2021/01/14/2159032/0/en/ClearPoint-Neuro-Inc-Announces-First-Procedure-Utilizing-ClearPoint-2-0-Software-in-Europe.html ...today reported the first utilization in Europe of its Version 2.0 software, together with the ClearPoint Neuro Navigation System, at Rigshospitalet in Copenhagen, Denmark. The procedure, which took place last week, also represents the first European site to use the ClearPoint System under live MRI guidance for navigation of a laser catheter in the brain. ...

Auf jeden Fall sollte sie hier bisher weniger bekannt sein. Für mich ein Wert, den ich definitiv nicht missen mag.

Geheimtipp?

ClearPoint Neuro, Inc. Reports Record Revenue in Preliminary Fourth Quarter 2020 Results https://www.globenewswire.com/news-release/2021/01/12/2157484/0/en/ClearPoint-Neuro-Inc-Reports-Record-Revenue-in-Preliminary-Fourth-Quarter-2020-Results.html ... Preliminary 2020 Results: Preliminary unaudited revenue for the fourth quarter of 2020 will be approximately $3.7 million, an increase of 14% over the same period in 2019. Preliminary revenue for the full-year 2020 will be an estimated $12.8 million, representing 14% growth from 2019. The Company supported 175 cases in the fourth quarter of 2020 against the backdrop of continued postponements of elective procedures due to the COVID-19 pandemic. Cash used in operations for the quarter and year ended December 31, 2020, is expected to be approximately $2.4 million and $7.9 million, respectively. The full-year amount includes the payment of $1.0 million in accumulated interest on secured indebtedness that the Company repaid in January 2020. The Company had approximately $20.1 million in cash and cash equivalents at December 31, 2020.   ...

Ist schon gut gelaufen, aber ich bin der Meinung, dass hier in 2021 die Post weiter abgehen wird. Meiner Meinung nach immer noch kaufenswert

ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of Existing Convertible Note on Improved Terms https://www.globenewswire.com/news-release/2020/12/29/2151415/0/en/ClearPoint-Neuro-Inc-Announces-Funding-of-Additional-7-5M-of-Existing-Convertible-Note-on-Improved-Terms.html Represents Draw of Additional Proceeds from Petrichor Announced in January 2020 ...

📎

Hier jemand dabei?